Deep dive into the components of GENESTACK. A systems-level reference for understanding how biological signals become compiled intervention stacks.
GENESTACK is a biological signal compiler. It does not diagnose. It does not prescribe. It reads the patterns your body produces — focus disruption, sleep fragmentation, fatigue accumulation, metabolic drift, recovery lag — and runs them through a structured gene expression inference layer to produce a compiled intervention stack.
The framework operates across five biological systems simultaneously: dopaminergic regulation, circadian rhythm integrity, inflammatory load, anabolic signaling, and metabolic efficiency. Each system is mapped to established gene-behavior relationships documented in peer-reviewed genomic and pharmacological literature.
The output is not a recommendation. It is a compiled signal readout — a systems-level interpretation expressed in the language of molecular biology, not consumer wellness.
Signal Capture to Gene Expression Inference to Stack Compilation to Constraint Validation to Output Rendering
All signal inputs are anonymized at ingestion. No personally identifiable biological data is stored. Aggregated signal patterns contribute to the GENESTACK network intelligence layer — a decentralized dataset that improves pattern recognition across all active profiles.
GENESTACK operates as an informational and experimental protocol system. All compounds referenced within compiled stacks are research-grade substances. Nothing within this framework constitutes medical advice, clinical guidance, or therapeutic recommendation. Users engage as autonomous biological experimenters contributing to a decentralized science network.
In the GENESTACK framework, a signal is any self-reported behavioral or physiological pattern that reflects the underlying state of a biological system. Signals are not biomarkers. They are not lab values. They are observable, repeatable patterns — the kind that accumulate over weeks and months before they manifest as measurable pathology.
The signal model is built on a foundational premise established across decades of psychoneuroimmunology and chronobiology research: phenotypic behavior is a reliable proxy for genotypic expression under chronic conditions. When a person consistently experiences burst-crash focus cycles, this is not random. It reflects a dopaminergic regulation pattern — most commonly associated with elevated COMT activity or reduced DRD2 receptor density — that produces downstream consequences.
Options: Stable / Burst-Crash / Low Drive
Biological relevance: Prefrontal cortex dopamine availability, COMT Val158Met polymorphism expression, D2 receptor binding affinity.
Options: Deep & Refreshed / Disturbed / Wired But Tired
Biological relevance: PER3 variable number tandem repeat (VNTR) expression, CLOCK gene transcription factor activity, melatonin secretion timing, cortisol awakening response (CAR).
Options: Rare Fatigue / Occasional Soreness / Persistent Fatigue
Biological relevance: TNF-α promoter polymorphism activity, IL-6 serum signaling patterns, NF-κB pathway activation, C-reactive protein (CRP) indirect indicators.
Options: Fast / Average / Slow
Biological relevance: IGF-1 axis output, myostatin (MSTN) suppression levels, satellite cell activation rates, mTORC1 pathway responsiveness.
Options: Lean / Balanced / Easy Fat Gain
Biological relevance: FTO rs9939609 variant expression, PPARγ transcriptional activity, insulin sensitivity indices, adiponectin signaling.
if (cognitiveSignal === "burst_crash") to COMT inferred: High Turnover if (cognitiveSignal === "low_drive") to DRD2 inferred: Low Sensitivity if (circadianSignal === "disturbed") to PER3 inferred: Downregulated if (circadianSignal === "wired_tired") to CLOCK inferred: Misaligned if (inflammatorySignal === "persistent") to TNF inferred: Elevated if (inflammatorySignal === "occasional") to IL6 inferred: Moderate if (recoverySignal === "slow") to IGF1 inferred: Low Signal if (recoverySignal === "fast") to MSTN inferred: Suppressed if (metabolicSignal === "fat_gain") to FTO inferred: Storage Bias if (metabolicSignal === "balanced") to PPARG inferred: Normal
GENESTACK does not sequence your genome. It does not read your DNA. What it does is substantially more practical for real-world application: it uses your reported phenotypic signals to infer the functional expression state of key regulatory genes — the genes most likely to be driving the patterns you experience.
This approach is grounded in a well-established principle in functional genomics: gene expression is not binary. Genes do not simply switch on or off. They upregulate, downregulate, compensate, and interact — and these states produce observable phenotypic outputs. The GENESTACK inference layer maps those outputs back to their most probable genomic origins.
Regulates dopamine degradation in the prefrontal cortex. High COMT activity accelerates dopamine breakdown, reducing sustained focus capacity. The Val158Met polymorphism is the most studied variant — Val/Val carriers show 3-4x faster dopamine metabolism than Met/Met carriers.
Primary post-synaptic dopamine receptor governing reward, motivation, and drive. Reduced receptor density or sensitivity produces anhedonia, low motivation, and difficulty initiating sustained effort.
Core component of the mammalian circadian clock. PER3 VNTR polymorphism (4-repeat vs 5-repeat) significantly impacts sleep architecture, slow-wave sleep depth, and subjective sleep quality. 5-repeat carriers show greater homeostatic sleep pressure and deeper slow-wave sleep.
Transcription factor that drives the primary feedback loop of the circadian clock. CLOCK gene variants are associated with delayed sleep phase, evening chronotype, and metabolic dysregulation under circadian misalignment conditions.
Primary pro-inflammatory cytokine governing systemic immune activation. TNF-α promoter polymorphisms (notably -308G/A) modulate baseline inflammatory tone. Elevated TNF-α expression is associated with chronic fatigue, muscle catabolism, and reduced anabolic responsiveness.
Pleiotropic cytokine with both pro- and anti-inflammatory roles. Acutely elevated during exercise (myokine function), chronically elevated in systemic inflammatory states. IL-6 excess impairs insulin signaling and disrupts sleep architecture via hypothalamic activation.
Primary anabolic hormone mediating growth hormone downstream signaling. IGF-1 drives muscle protein synthesis, satellite cell activation, and tissue repair cascades. Low IGF-1 axis output produces slow recovery, reduced lean mass accrual, and blunted adaptation to training stress.
Negative regulator of skeletal muscle growth. MSTN suppression allows greater muscle fiber hypertrophy and accelerated recovery from mechanical loading. Natural MSTN suppression variants produce unusually fast recovery and muscle growth rates.
RNA demethylase involved in energy homeostasis regulation. FTO rs9939609 risk allele (A variant) is associated with increased energy intake, reduced satiety signaling, and preferential energy storage as adipose tissue. Carriers show 20-30% increased obesity risk independent of lifestyle factors.
Master transcriptional regulator of adipogenesis and insulin sensitivity. PPARγ governs fat cell differentiation, glucose uptake, and lipid metabolism. Normal PPARγ activity maintains metabolic flexibility — the ability to efficiently switch between glucose and fatty acid oxidation.
The Stack Compiler is the core output engine of GENESTACK. Once all five signal modules have been processed and gene expression states have been inferred, the compiler aggregates all indicated compounds, eliminates redundancies, scores system coverage, and produces a ranked intervention stack.
The compiler operates on three principles:
Each compound in the stack is selected for its documented interaction with a specific biological pathway identified as suboptimal through signal inference. No compound is included without a mapped gene-pathway justification.
Where a single compound addresses multiple inferred expression states simultaneously — such as BPC-157 addressing both inflammatory load (TNF/IL6 pathway) and recovery signaling (IGF-1 axis) — it is compiled once and its cross-module coverage is reflected in the coverage score.
Before finalization, every compiled stack passes through the global Risk Engine to identify pharmacodynamic interactions, axis overlaps, and stimulatory conflicts. Flagged conflicts are surfaced in the output dashboard under Key Constraints.
BPC-157 accelerates tissue repair through upregulation of growth factor expression (VEGF, EGF) and modulation of the NO-system. Demonstrated efficacy in tendon, ligament, muscle, and gut mucosal repair in preclinical models. Also exhibits neuroprotective and dopaminergic stabilizing properties.
CJC-1295 with DAC binds and stimulates pituitary GHRH receptors, producing sustained elevation of growth hormone pulsatility and downstream IGF-1 production. Half-life of 6-8 days with DAC modification. Supports lean mass preservation, fat metabolism, and recovery optimization.
AOD-9604 mimics the lipolytic activity of the C-terminal region of human growth hormone without affecting IGF-1 levels or inducing insulin resistance. Activates β3-adrenergic receptors to stimulate fat oxidation, particularly visceral adipose tissue.
Semax increases BDNF and NGF expression in the prefrontal cortex, enhances dopaminergic and serotonergic neurotransmission, and demonstrates neuroprotective effects under stress conditions.
Bromantane upregulates tyrosine hydroxylase and DOPA decarboxylase enzymes — the rate-limiting steps in dopamine biosynthesis — producing sustained increases in dopamine availability without receptor downregulation.
DSIP modulates delta wave sleep, reduces cortisol stress responses, and exhibits antioxidant properties. Normalizes disrupted sleep patterns in models of chronic stress and circadian misalignment.
TB-500 upregulates actin expression (a key structural protein in cellular repair), reduces inflammatory cytokine production, and accelerates wound healing.
Coverage % = (Active Modules Addressed / Total Modules) x Compound Efficacy Weight Redundancy Score = Duplicate Compounds Removed / Total Compounds Selected Final Stack Score = Coverage % adjusted for Risk Engine flags
A compiled stack is only as good as its conflict screening. Biological systems do not operate in isolation — compounds that individually address specific pathways can interact unfavorably when combined, particularly across growth, hormonal, and stimulatory axes. The GENESTACK Constraint Engine runs every compiled stack through a set of globally defined rules before output is rendered.
Constraints are not prohibitions. They are system flags — signals that a particular combination warrants additional consideration, cycle management, or sequencing strategy.
Trigger: Two or more GH-axis compounds present in compiled stack (e.g., CJC-1295 + AOD-9604 + TB-500)
Rationale: Concurrent activation of multiple GH-axis pathways risks receptor desensitization, IGF-1 dysregulation, and suppression of endogenous GH pulsatility. Sequencing or cycling protocols are recommended over simultaneous stacking.
Recommended Action: Prioritize primary GH compound. Introduce secondary compound in subsequent cycle.
Trigger: Dopamine-modulating compound (Semax, Bromantane) present alongside high inflammatory load signal
Rationale: Elevated systemic inflammation (high TNF-α, IL-6) impairs dopaminergic neurotransmission through neuroinflammatory mechanisms. Adding stimulatory dopaminergic compounds under high inflammatory load may produce paradoxical fatigue or anxiety amplification.
Recommended Action: Prioritize inflammatory load reduction (BPC-157, TB-500) before introducing cognitive modulation layer.
Trigger: AOD-9604 compiled alongside CJC-1295
Rationale: While AOD-9604 is specifically designed to avoid IGF-1 elevation, its concurrent use with GHRH analogues that increase total GH output requires monitoring of glucose metabolism markers. Individual metabolic responses vary significantly based on FTO and PPARG expression states.
Recommended Action: Baseline fasting glucose and insulin monitoring recommended. Protocol logging via Experiment Module advised.
Trigger: Four or more compounds compiled simultaneously
Rationale: Multi-compound stacks reduce the ability to isolate individual compound effects, complicate side-effect attribution, and increase inter-compound interaction probability. DeSci best practice favors staged introduction with outcome logging.
Recommended Action: Introduce compounds in order of module priority. Log each phase in Experiment Timeline.
The Experiment System is GENESTACK's DeSci data layer. It transforms individual protocol runs into network intelligence — anonymized, aggregated, and returned to the community as pattern insights that no single user could generate alone.
Every user who logs a protocol run contributes to a growing dataset of signal-stack-outcome relationships. This dataset is the scientific foundation of GENESTACK's long-term value proposition: a continuously improving biological signal network built on real human data, not controlled trial populations.
User compiles a stack through the standard Signal to Gene to Stack flow. Compiled stack is saved as an active protocol with start date, compound list, and inferred expression profile recorded.
At defined intervals (Day 7, Day 14, Day 21, Day 30), users log outcome signals using the same 5-category signal framework. Delta is calculated automatically.
Users record qualitative outcome notes and quantitative signal deltas.
Outcome data is anonymized. Personally identifiable information is stripped at the protocol level. Only signal profile, stack composition, and duration are retained.
"89 profiles with similar COMT high-turnover + IGF1 low-signal expression reported improved cognitive stability and recovery speed within 14 days of BPC-157 + Semax protocol."
{
"protocol_id": "GS-2024-00847",
"signal_profile": {
"cognitive": "burst_crash",
"circadian": "disturbed",
"inflammatory": "occasional",
"recovery": "slow",
"metabolic": "balanced"
},
"compiled_stack": ["BPC-157", "CJC-1295", "Semax"],
"duration_days": 14,
"coverage_score": 82,
"outcome_deltas": {
"cognitive": +2,
"recovery": +1,
"circadian": 0
},
"community_match_count": 89,
"anonymized": true
}The GENESTACK API provides programmatic access to the signal processing engine, gene expression inference layer, stack compilation logic, and experiment network data. Designed for researchers, biohackers, protocol developers, and DeSci application builders who want to integrate GENESTACK intelligence into external tools and workflows.
Submit a signal profile and receive gene expression inference + compiled stack output.
Request:
{
"signals": {
"cognitive": "burst_crash",
"circadian": "wired_tired",
"inflammatory": "persistent",
"recovery": "slow",
"metabolic": "easy_fat_gain"
}
}
Response:
{
"expression_map": {
"COMT": "high_turnover",
"CLOCK": "misaligned",
"TNF": "elevated",
"IGF1": "low_signal",
"FTO": "storage_bias"
},
"compiled_stack": ["BPC-157", "CJC-1295", "AOD-9604", "Semax"],
"coverage_score": 82,
"redundancy": "low",
"constraints": ["growth_axis_overlap", "dopamine_inflammation_flag"]
}Retrieve reference data for a specific gene including function, variants, and GENESTACK inference states.
GET /genes/COMT | GET /genes/IGF1 | GET /genes/FTORetrieve compound reference data including mechanism, pathway mapping, and module associations.
GET /compounds/bpc-157 | GET /compounds/semax | GET /compounds/cjc-1295# Install CLI packages
npm install @genestack/sdk
pip install genestack-sdk
// Node.js Implementation
import { GenestackClient } from '@genestack/sdk';
const client = new GenestackClient({ apiKey: 'your_api_key' });
const result = await client.signals.analyze({
cognitive: 'burst_crash',
circadian: 'disturbed',
recovery: 'slow'
});
console.log(result.compiledStack);
// to ['BPC-157', 'CJC-1295', 'Semax']